145 related articles for article (PubMed ID: 20437261)
21. Stage-specific expression of breast cancer-specific gene gamma-synuclein.
Wu K; Weng Z; Tao Q; Lin G; Wu X; Qian H; Zhang Y; Ding X; Jiang Y; Shi YE
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):920-5. PubMed ID: 14504205
[TBL] [Abstract][Full Text] [Related]
22. Extracellular gamma-synuclein promotes tumor cell motility by activating β1 integrin-focal adhesion kinase signaling pathway and increasing matrix metalloproteinase-24, -2 protein secretion.
Liu C; Qu L; Zhao C; Shou C
J Exp Clin Cancer Res; 2018 Jun; 37(1):117. PubMed ID: 29903032
[TBL] [Abstract][Full Text] [Related]
23. Alternative splicing of synuclein gamma in endometrial cancer: identification of a novel isoform.
Schaal K; Hirschfeld M; Bronsert P; Füllgraf H; Jäger M; Herde B; Nöthling C; Mayer S; Erbes T; Stickeler E
Oncotarget; 2015 Sep; 6(26):22553-63. PubMed ID: 26265438
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of synuclein-γ predicts lack of benefit from radiotherapy for breast cancer patients.
Min L; Zhang C; Ma R; Li X; Yuan H; Li Y; Chen R; Liu C; Guo J; Qu L; Shou C
BMC Cancer; 2016 Sep; 16(1):717. PubMed ID: 27595752
[TBL] [Abstract][Full Text] [Related]
25. Structural insights into tumor-specific chaperoning activity of gamma synuclein in protecting estrogen receptor alpha 36 and its role in tamoxifen resistance in breast cancer.
Panneerselvam M; Muthu K; Ramadas K
Mol Biosyst; 2015 Nov; 11(11):2998-3010. PubMed ID: 26299756
[TBL] [Abstract][Full Text] [Related]
26. Synuclein-γ (SNCG) expression in ovarian cancer is associated with high-risk clinicopathologic disease.
Strohl A; Mori K; Akers S; Bshara W; Buttin B; Frederick PJ; Helenowski IB; Morrison CD; Odunsi K; Schink JC; Scholtens DM; Wei JJ; Kim JJ
J Ovarian Res; 2016 Nov; 9(1):75. PubMed ID: 27809878
[TBL] [Abstract][Full Text] [Related]
27. Stimulation of estrogen receptor signaling by gamma synuclein.
Jiang Y; Liu YE; Lu A; Gupta A; Goldberg ID; Liu J; Shi YE
Cancer Res; 2003 Jul; 63(14):3899-903. PubMed ID: 12873981
[TBL] [Abstract][Full Text] [Related]
28. Synuclein-gamma (SNCG) may be a novel prognostic biomarker in uterine papillary serous carcinoma.
Morgan J; Hoekstra AV; Chapman-Davis E; Hardt JL; Kim JJ; Buttin BM
Gynecol Oncol; 2009 Aug; 114(2):293-8. PubMed ID: 19476987
[TBL] [Abstract][Full Text] [Related]
29. Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers.
Liu H; Liu W; Wu Y; Zhou Y; Xue R; Luo C; Wang L; Zhao W; Jiang JD; Liu J
Cancer Res; 2005 Sep; 65(17):7635-43. PubMed ID: 16140929
[TBL] [Abstract][Full Text] [Related]
30. Cigarette smoke induces demethylation of prometastatic oncogene synuclein-gamma in lung cancer cells by downregulation of DNMT3B.
Liu H; Zhou Y; Boggs SE; Belinsky SA; Liu J
Oncogene; 2007 Aug; 26(40):5900-10. PubMed ID: 17369845
[TBL] [Abstract][Full Text] [Related]
31. Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study.
Winder AD; Maniar KP; Wei JJ; Liu D; Scholtens DM; Lurain JR; Schink JC; Buttin BM; Filiaci VL; Lankes HA; Ramirez NC; Park K; Singh M; Lieberman RW; Mannel RS; Powell MA; Backes FJ; Mathews CA; Pearl ML; Secord AA; Peace DJ; Mutch DG; Creasman WT; Kim JJ
Cancer; 2017 Apr; 123(7):1144-1155. PubMed ID: 27926776
[TBL] [Abstract][Full Text] [Related]
32. Expression of γ-Synuclein in Bladder Carcinoma: A Possible Marker for Prognosis.
Chen Z; Ji Z; Wang Q; Shi B; Shou C; Liu C; Fan H; Li H; Davidson KT; Wakefield MR; Ball TW; Fang Y
Anticancer Res; 2016 Mar; 36(3):951-6. PubMed ID: 26976983
[TBL] [Abstract][Full Text] [Related]
33. SNCG shRNA suppressed breast cancer cell xenograft formation and growth in nude mice.
Shen PH; Fan QX; Li YW; Zhang W; He XK; Wang Z; Zhang YH
Chin Med J (Engl); 2011 May; 124(10):1524-8. PubMed ID: 21740810
[TBL] [Abstract][Full Text] [Related]
34. HBP21: a novel member of TPR motif family, as a potential chaperone of heat shock protein 70 in proliferative vitreoretinopathy (PVR) and breast cancer.
Liu Q; Gao J; Chen X; Chen Y; Chen J; Wang S; Liu J; Liu X; Li J
Mol Biotechnol; 2008 Nov; 40(3):231-40. PubMed ID: 18587674
[TBL] [Abstract][Full Text] [Related]
35. Relationship of SNCG, S100A4, S100A9 and LCN2 gene expression and DNA methylation in bladder cancer.
Dokun OY; Florl AR; Seifert HH; Wolff I; Schulz WA
Int J Cancer; 2008 Dec; 123(12):2798-807. PubMed ID: 18803290
[TBL] [Abstract][Full Text] [Related]
36. Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1.
Gupta A; Inaba S; Wong OK; Fang G; Liu J
Oncogene; 2003 Oct; 22(48):7593-9. PubMed ID: 14576821
[TBL] [Abstract][Full Text] [Related]
37. Abnormal activation of the synuclein-gamma gene in hepatocellular carcinomas by epigenetic alteration.
Zhao W; Liu H; Liu W; Wu Y; Chen W; Jiang B; Zhou Y; Xue R; Luo C; Wang L; Jiang JD; Liu J
Int J Oncol; 2006 May; 28(5):1081-8. PubMed ID: 16596223
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the synuclein-γ (SNCG) gene as a PPARγ target in murine adipocytes, dorsal root ganglia somatosensory neurons, and human adipose tissue.
Dunn TN; Akiyama T; Lee HW; Kim JB; Knotts TA; Smith SR; Sears DD; Carstens E; Adams SH
PLoS One; 2015; 10(3):e0115830. PubMed ID: 25756178
[TBL] [Abstract][Full Text] [Related]
39. [SNCG expression and clinical significance in colorectal cancer liver metastasis].
Guo CG; Sun LC; Liu Q; Xie YB; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Jun; 15(6):625-8. PubMed ID: 22736138
[TBL] [Abstract][Full Text] [Related]
40. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
